LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway

Temozolomide (TMZ) is the most commonly used alkylating agent in glioma chemotherapy. However, growing resistance to TMZ remains a major challenge for clinicians. Recent evidence emphasizes the key regulatory roles of non-coding RNAs (lncRNAs and miRNAs) in tumor biology, including the chemoresistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Peng, Zhao, Haiting, Peng, Renjun, Liu, Qing, Yuan, Jian, Peng, Gang, Liao, Yiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587918/
https://www.ncbi.nlm.nih.gov/pubmed/28831025
http://dx.doi.org/10.1042/BSR20170696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587918/
https://www.ncbi.nlm.nih.gov/pubmed/28831025
http://dx.doi.org/10.1042/BSR20170696

Ejemplares similares